All Stories

  1. Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, June 2020, Bentham Science Publishers

    Dr Maria John Newton Amaldoss

  2. Synthesis and Characterization of Valacyclovir HCl Hybrid Solid Lipid Nanoparticles by Using Natural Oils

    Article • Recent Patents on Drug Delivery & Formulation, July 2019, Bentham Science Publishers

    MARIAJOHNNEWTON AMALDOSS, Dr Maria John Newton Amaldoss

  3. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study

    Article • Recent Patents on Drug Delivery & Formulation, December 2017, Bentham Science Publishers

    Dr Maria John Newton Amaldoss

  4. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD)

    Article • Recent Patents on Inflammation & Allergy Drug Discovery, August 2017, Bentham Science Publishers

    Dr Maria John Newton Amaldoss

  5. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, April 2017, Bentham Science Publishers

    Dr Maria John Newton Amaldoss

  6. Flunarizine Dihydrochloride Nanoemulsion for Migraine Nasal Drug Delivery: Fabrication, Characterization and In Vitro Study

    Article • Drug Delivery Letters, January 2017, Bentham Science Publishers

    MARIAJOHNNEWTON AMALDOSS, Dr Maria John Newton Amaldoss

  7. Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, December 2016, Bentham Science Publishers

    MARIAJOHNNEWTON AMALDOSS, Dr Maria John Newton Amaldoss

  8. Fabrication and Evaluation of Fast Disintegrating Oral Hybrid Films of Propranolol Hydrochloride by Using Pectin and Synthetic Polymers

    Article • Journal of Developing Drugs, January 2016, OMICS Publishing Group

    Dr Maria John Newton Amaldoss

  9. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation

    Article • International Journal of Biological Macromolecules, August 2015, Elsevier

    Dr Maria John Newton Amaldoss

  10. IBD Modern Concepts, Nano Drug Delivery and Patents: An Update

    Article • Recent Patents on Nanomedicine, July 2015, Bentham Science Publishers

    Dr Maria John Newton Amaldoss

  11. Effect of HPMC - E15 LV premium Polymer on Release Profile and Compression Characteristics of Chitosan/ Pectin Colon Targeted Mesalamine Matrix Tablets and in vitro Study on Effect of pH Impact on the Drug Release Profile

    Article • Recent Patents on Drug Delivery & Formulation, April 2014, Bentham Science Publishers

    MARIAJOHNNEWTON AMALDOSS, Dr Maria John Newton Amaldoss

  12. IBD Impact of Colonic pH, Onset of Action and other Factors in Modern Therapeutic Approach

    Article • Interdisciplinary Journal of Microinflammation, January 2014, OMICS Publishing Group

    Dr Maria John Newton Amaldoss

  13. Formulation and in-vitro evaluation of moxifloxacin loaded crosslinked chitosan films for the treatment of periodontitis

    Article • Journal of Pharmacy Research, June 2013, Elsevier

    Dr PRAKASH KATAKAM, Dr Maria John Newton Amaldoss

  14. Article • International Journal of Pharmaceutical Sciences and Research, July 2012, International Journal of Pharmaceutical Sciences and Research

    Dr Maria John Newton Amaldoss

  15. Formulation development, optimization and study on drug release kinetics of Eudragit®L100-HPMC E15 LV mixed film-coated colon-targeted Mesalamine tablets

    Article • Asian Journal of Pharmaceutics, January 2012, BRNSS Publication Hub

    Dr Maria John Newton Amaldoss